Risk factors for COVID-19 and their association with mortality in Ecuadorian patients admitted to the ICU: A retrospective cohort multicentric study

Author:

Fuenmayor-González Luis1,Vera-Ormaza Jair2,Shen Hua3,Corella-Ortega Belén2,Fajardo-Loaiza Thalía1,Borja-Pérez Cristina2,Ochoa-Godoy Nancy2,Vásquez-Barzallo Sebastián2,Díaz-Rodríguez Juan2,Díaz Ana María4,García Fernanda4,Ramírez Vanessa4,Sánchez Hernán4,Barberán José Luis5,Paredes Juan Pablo5,Cevallos Mónica5,Montenegro Francisco6,Puertas Soraya6,Briones Killen7,Martínez Marlon7,Vélez-Páez Jorge8,Montalvo-Villagómez Mario8,Herrera Luis9,Garrido Santiago9,Sisa Ivan10ORCID,Jibaja Manuel410

Affiliation:

1. Facultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, Ecuador

2. Servicio de Emergencias, Hospital Pablo Arturo Suárez, Quito, Ecuador

3. Department of Mathematics and Statistics, University of Calgary, Calgary, Alberta, Canada

4. Unidad de Cuidados Intensivos, Hospital de Especialidades Eugenio Espejo, Quito, Ecuador

5. Unidad de Cuidados Intensivos, Hospital de Especialidades, Portoviejo, Ecuador

6. Unidad de Cuidados Intensivos, Hospital de Especialidades José Carrasco Arteaga, Cuenca, Ecuador

7. Unidad de Cuidados Intensivos, Hospital del IESS, Babahoyo, Ecuador

8. Unidad de Cuidados Intensivos, Hospital General Pablo Arturo Suárez, Quito, Ecuador

9. Unidad de Cuidados Intensivos, Hospital del IESS, Ibarra, Ecuador

10. Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.

Abstract

Several risk factors were associated with mortality in patients with coronavirus disease 2019 (COVID-19) infection in intensive care units (ICU). We assessed the effect of risk factors related to the characteristics and clinical history of the population, laboratory test results, drug management, and type of ventilation on the probability of survival/discharge from the ICU. A retrospective cohort multicentric study of adults with COVID-19 admitted to the ICU between March 2020 and December 2021. Data were collected from 6 hospitals in 5 cities in Ecuador. The primary outcome was ICU survival/discharge. Survival analysis was conducted using semi-parametric Cox proportional hazards models. Of those admitted to the ICU with COVID-19, (n = 991), mean age was 56.76 ± 13.14, and 65.9% were male. Regarding the primary outcome, 51.1% (n = 506) died and 48.9% (n = 485) survived. Of the group that died, their mean age was higher than the survivors (60.7 vs 52.60 years, respectively), and they had a higher prevalence of comorbidities such as arterial hypertension (37.2% vs 20.4%, respectively) and diabetes mellitus (26.9% vs 15.7%, respectively), with P < .001. In ventilatory management, 32.7% of patients used noninvasive ventilation and high-flow nasal cannula, and 67.3% required invasive ventilatory support. After adjusting for confounders, Cox regression analysis showed that patients were less likely to be discharged alive from the ICU if they met the following conditions: arterial hypertension (hazard ratio [HR] = 0.83 95% CI 0.723–0.964), diabetes mellitus (HR = 0.80 95% CI 0.696–0.938), older than 62 years (HR = 0.86 95% CI 0.790–0.956), obese (body mass index ≥ 30) (HR = 0.78 95% CI 0.697–0.887), 1 unit increase in SOFA score (HR = 0.94 95% CI 0.937–0.961), PaO2/FiO2 ratio <100 mm Hg (HR = 0.84 95% CI 0.786–0.914), and the use of invasive mechanical ventilation (HR = 0.68 95% CI 0.614–0.769). Risk factors associated with increased mortality were older age, obesity, arterial hypertension, and diabetes. Factors such as male gender, chronic obstructive pulmonary disease, acute kidney injury, and cancer reported in other investigations did not have the same effect on mortality in our study.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference38 articles.

1. The trinity of COVID-19: immunity, inflammation and intervention.;Tay;Nat Rev Immunol,2020

2. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Geneva: World Health Organization; 2020

3. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data.

4. Datos epidemiológicos COVID-19.,2023

5. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention.;Wu;JAMA,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3